these advantages, infective complications including peritonitis (about 0.3-0.5 episodes per patient per year) remain a major cause of drop out from PD programmes. PD peritonitis is also a common cause of catheter loss and transfer to haemodialysis (HD). [5] Multiple factors such as socio-demographic, climate change, diabetes mellitus, PD modality and the presence of peritoneal catheter tunnel infection or exit site infection are risk factors associated with the development of peritonitis. However, early diagnosis and prompt initiation of therapy for peritonitis are critical, and can prevent adverse outcomes. [6] For an appropriate management, it is also important to identify the microorganisms that are responsible for peritonitis. [7, 8] Hence, the recent focus has been shifting from lowering peritonitis rates to the improvement of peritonitis outcome. [7] [8] [9] Existing Indian evidence is limited to mostly being single-centred studies. There is a paucity of data to guide appropriate and evidence-based therapeutic choices. Hence, considering the need of a large, multi-centre epidemiological data on the prevention and management of PD-related peritonitis in India, the present prospective study was envisaged as the largest nationwide observational study.
methodology

Study design and objectives
The present study was an open-label, prospective, observational study conducted in 21 centres representing all the four geographical regions (North, South, East and West) of India, from April 2010 to December 2011. The study was approved by Independent Ethics Committee and written informed consent was obtained from all the study participants. The primary objective was to describe the epidemiology of aetiological organisms, including the incidence and distribution of culture-negative peritonitis. Secondary objectives included the assessment of clinical course and demographic risk factors, evaluation of techniques for isolation and identification of microorganism, antibiotic sensitivity of isolates, treatment protocols and peritonitis outcomes.
Sample size determination
Sample size calculation was based on a previous Indian study, in which Gram-negative, Gram-positive, polymicrobial and fungal peritonitis were found to be 42.45%, 28.30%, 10.38% and 18.87%, respectively. [10] Weighted percentage peritonitis of 30.67% was calculated. Based on the anticipated peritonitis of 30.67%, 95% of confidence level and 7% margin of absolute error, a sample of 168 episodes of peritonitis were calculated. To compensate for variations between and within centres, the calculated sample was multiplied by a factor of two (design effect), giving the revised sample size of 336. Considering the dropout rate of 20%, sample size was finally adopted as 400 episodes of peritonitis.
Study population Inclusion criteria
The present study included patients who have been diagnosed to have peritonitis following PD. PD peritonitis was defined as the presence of two of the three ISPD 2010 peritonitis diagnostic criteria. [8] 
Exclusion criteria
Patients with a history of peritonitis in the past 1 month or those who received antibiotics within 7 days before enrollment (without an exit site infection) or concurrent the presence of any malignancy or on immunosuppressants (except topical steroid) were excluded from the study.
Study procedure
Eligible participants were recruited, and the following information was collected at baseline. 
Follow-up visits, data collection, treatment
Empirical antibiotics were started as per centre specific protocols and were thereafter revised based on culture sensitivity reports. All the study participants were followed up on day 3 ± 1 (visit 2), 5 ± 1 (visit 3), 7 ± 1 (visit 4), 14 ± 2 (visit 5) and 45 + 7 (visit 6). All the above-mentioned information except for microbiological investigations were collected at all these time points. Based on investigator discretion, a repeat culture was also done at visit 5. Peritonitis related deaths in the present study were defined as death due to sepsis, death occurring with a positive PD culture, death within 14 days after onset of peritonitis or death occurring during hospitalisation for any patient admitted with peritonitis. [10] 
Culture techniques
Being an observational study, no particular culture method was made mandatory, although all the study centres were advised to use the methods recommended in ISPD 2010 guidelines. [8] Both conventional (agar and broth method) and automated culture methods (e.g., BACTEC, Septi-Chek, BacT/Alert) were permitted due to limitations of cost and resources at different centres. Automated methods are blood culture systems which process test samples and analyse results to data, and generate an interpretation using computing programmes. The conventional method involved manual inoculation and enrichment step followed by plating with selective media. Before and during the study, meetings and training programmes were conducted to spread the awareness of proper culture techniques across the participating centres to optimise the chances of successful isolation and identification of aetiological microorganisms.
Statistical analysis
The frequency distribution of some quantitative variables such as age, height, body mass index and socio-economic status was classified into different class-intervals. The qualitative variables such as education, employment, marital status, gender, hygiene, geographical location, source of water and co-morbidity were expressed with regard to percentage. Percentage of peritonitis caused by Gram-positive, Gram-negative organisms, Mycobacterium tuberculosis, fungus and of culture negative peritonitis were estimated. All the quantitative variables were assessed for normality and accordingly Student's t-test was employed. The categorical variables were represented in proportions and analysed using Chi-square test after checking for assumptions. The value of P < 0.05 was considered as statistically significant for all the statistical tests.
Results
Demographic data
A total of 244 patients with peritonitis were enrolled in the study. The mean (standard deviation) age (years) was 54.30 (13.1) and body mass index (kg/m 2 ) of the study participants was 23.15 (4.5), respectively. The median (range) duration (years) of ESRD was 2.75 (0.05-18.87) and that of peritoneal catheterisation was 1.26 (0.03-15.62), respectively. A total of 61 (25%) participants were new to PD and 177 (72.5%) had undergone a previous HD, while 6 (2.5%) had a failed previous kidney transplant. Of the 244 participants, 239 (98%) were on continuous ambulatory PD mode with a median (range) duration (months) of 15.76 (0.4-187.3) and only 5 (2%) were on automated PD with a median duration (months) of 7.13 (4.7-12.3). Table 1 summarises the demographic characteristics of the study participants.
Reviewing the clinical consideration and presence of co-morbid disease, a total of 106 (43.4%) patients had diabetic nephropathy, 96 (39.3%) had hypertensive nephropathy. The remaining 42 (17.3%) had underlying chronic glomerulonephritis, chronic interstitial nephritis, obstructive nephropathy, toxic nephropathy, polycystic kidney disease and renovascular disease. 
Peritoneal dialysis catheterisation
Previous episodes, latency and seasonality of peritonitis
Antibiotics for management of peritonitis
As a prophylactic care during catheter implantation, antibiotics were administered to 243 (99.6%) patients. The most commonly used antibiotic was vancomycin 1 g (35.4%). Cefazolin (30.9%) and tobramycin (16.5%) were the other most commonly used antibiotic.
Clinical outcome
Of the total 244 patients with peritonitis, 6 dropped out after first visit. A total of 179 participants completed the study. Figure 1 depicts the patient flow from the time of recruitment to the completion of the last study visit. During the last study visit, there were a total of 13 study participants with peritonitis. PD effluent cell count was analysed only for these study participants and was found to be elevated. The clinical outcomes were similar in both culture positive and negative peritonitis patients. Recovery from peritonitis was seen in 68.2% of culture positive cases and 71.1% culture negative patients. In addition, 20% and 18.8% of patients were switched to either HD or renal transplantation, 9.4% and 3.8% died, 1.2% and 4.4% had on-going infections and 1.2% and 1.9% was lost to follow-up in culture positive and culture negative group.
Further we found that, out of 18 patients with E. coli infection, 12 (66.7%) recovered from peritonitis, 1 (5.6%) switched to HD and 5 (27.8%) died. Mortality was also recorded in 2/8 (20%) who grew Staphylococcus aureus, 1 each with Acinetobacter sp (n = 3). and M. tuberculosis (n = 1) died. The best outcomes were observed in patients with peritonitis caused by coagulase negative staphylococci (n = 16), in which 14 (87.5%) patients recovered from peritonitis, 2 (12.5%) switched to other modality, while none died as shown in Table 4 . Most of the individuals infected with Candida spp., (n = 12) had switch to other modalities of renal replacement therapy following catheter removal (9, 75%) after a median duration of 14 days. E. coli, coagulase negative Staphylococci, Candida spp., Klebsiella pneumonia and S. aureus were the most frequent microorganisms responsible for hospitalisation of the patients. Statistical correlations were not made due to less number in each individual group.
dIscussIon
The present study is the largest multi-centre nation-wide study from India reporting the pattern and outcomes of peritonitis from various geographical regions of the country. A proper understanding of the patterns of occurrence of peritonitis in patients on PD, their natural history in the course of therapy, and the various predisposing factors that identify patients at risk is crucial to therapeutic and prophylactic interventions. [11] The present study demonstrated a very high culture negativity rate (65.3%), value far greater than that suggested in ISPD guidelines (<20%). A culture negativity rate between 28% and 70% has been observed in several studies with conventional culture technique. [10, [12] [13] [14] Non-adherence to ISPD recommendations with regard to culture specimen collection and processing methods along with discordance in sampling technique might have resulted in high culture negativity rates. A study from South India had a culture negativity rate of 50% even with the use of automated system. [7] Similar to this, we also found that when culture and sensitivity testing was done by automated technique, nearly 45% of the samples showed a growth of microorganisms as against 32% with the conventional techniques. Reason for culture negative peritonitis can be attributed to either use of conventional techniques versus automation, use of substandard media for culture, especially in the public sector hospitals and sub-optimal microbiological techniques. However, the number of samples was small to draw firm conclusions.
Increased incidence of Gram-negative organisms, unlike the western literature, has been encountered in other studies in India. [10, 14] Sharma et al. from North India had shown a predominance of Gram-negative organisms (60%-66%) with E. coli being most frequently isolated. [12, 13, 15] Gupta et al. reported higher incidence of Gram-positive (55.5%) than Gram-negative organisms (45%) in South India. [7] In this study, 47.8% Gram-negative and 36.7% Gram-positive microorganism were isolated, respectively. E. coli was the most common (20%) followed by Coagulase Negative Staphylococci (17.7%) of the total microorganism isolated. The incidence of fungal peritonitis in the present study (13.3%) was found to be similar to previous studies from India. [7, 13, 16] A study by Lo et al. found that use of antifungal prophylaxis during any antibiotic therapy resulted in decreased risk of Candida peritonitis. [17] Hospitalisation was necessary in about 71% of total peritonitis episodes in this study, which is consistent with the literature. The data are similar to that of a study by Ghali et al. wherein hospitalisation occurred for 70% of total episodes. [18] Proper treatment is crucial for favourable outcome of PD-related peritonitis. Inadequate culture facilities in many hospitals are contributing to the need for broad spectrum empirical antibiotics, which are expensive and drives the emergence of antimicrobial resistance. [19] Though initial empirical antibiotic prescription is recommended, it is generally expected that local epidemiology and sensitivity pattern should guide the appropriate antibiotic selection. According to ISPD guidelines also, the initial treatment of peritonitis (prior to the results of microbiological tests) should be based on a combination of drugs for coverage of Gram-positive cocci and Gram-negative organisms. [6] In the present study, vancomycin (54.9%), cefazolin (43.4%) and ceftazidime (42.2%) were the most frequently prescribed antimicrobials. Gram-positive organisms may respond to vancomycin or a cephalosporin, and Gram-negative organisms to a third generation cephalosporin or aminoglycoside.
Although ISPD guidelines recommend a beta-lactam and use of vancomycin to be restricted to patients with methicillin-resistant S. aureus, we found vancomycin being the preferred empirical antimicrobial in our study. [6] The choice of empiric outpatient treatment is dictated by convenience of self-administration by the patient and by the drug's pharmacokinetics, its cost, and its effectiveness. The pharmacokinetics of vancomycin allows IP dosing at weekly intervals. [20] In addition, Santoianni et al. 2008 recommended vancomycin plus ceftazidime or imipenem as the empirical antibiotics in the long term study. [21] A study which compared the efficacy of vancomycin versus cefazolin in PD peritonitis patients found that patient compliance and satisfaction was better with vancomycin than cefazolin when used as empirical antimicrobial. [22] In our study, 171 (95.5%) patients recovered from peritonitis at the end of trial. The clinical recovery was similar in both culture positive (68.2%) and negative (71.1%) peritonitis. Recovery from peritonitis was higher in Gram-positive than Gram-negative peritonitis and the mortality rate was higher for Gram-negative than for Gram-positive infections, which is similar to other reports including from India. [14, [23] [24] [25] High recovery rate may point towards the proper and timely use of empirical antibiotics and later supported by culture and antibiotic susceptibility results. Furthermore, continuous review of every episode of infection and timely change of interventions may have helped to improve outcomes.
However, this being an observational study has its own limitations. Observational studies are not scientifically capable of proving or disproving hypothesis. The same also applies to this epidemiological study due to the heterogeneity of real-life patient populations, the lack of standardised culture methods, treatment regimens and standardised indications for change of treatment. Furthermore, the total sample could not be recruited despite extending the enrolment period.
conclusIon
This first report from a large database offers insight into the aetiology and outcomes of PD related peritonitis in India, which are germane to clinical decision-making. The study has described the demography, microbiology, treatment and outcomes of peritonitis in Indian PD patients. Information regarding the seasonal trend and outcomes of peritonitis based on causative organism may help to identify patients with poor prognosis and take preventive and proper therapeutic measures. Much remains to be learned, and several areas require further research. A more detailed knowledge of the reasons for high culture negativity and resistance profiles of the causative organisms is needed to guide appropriate antibiotic therapy and improve peritonitis outcome.
